India’s New Drugs, Medical Devices, And Cosmetics Draft Bill 2022
By Mathini Ilancheran
Published in: Pharmaceutical online
Published on: November 7, 2022
To accommodate changing requirements and encourage the adoption of new technology, India’s Ministry of Health and Family Welfare released a draft bill in July 2022 to replace the existing Drugs and Cosmetics Act 1940. This act governs drug importation, production, and distribution across the country. The act's main goal is to ensure that all drugs and cosmetics sold in India are safe, effective, and meet international standards.1 It also focuses on ensuring the quality, safety, efficacy, and performance of new drugs, as well as on the clinical investigation of investigational medical devices. Finally, it adds regulations and restrictions on drug imports aimed at protecting public health interests. Below are some of the areas most highly impacted by this new bill.
If you have not yet signed up for the StabilityHub newsletter, join hundreds of other stabilitarians to get the latest news, publications, job opportunities and more!
By submitting this form, you are consenting to receive emails from: StabilityHub, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact